187 related articles for article (PubMed ID: 32907840)
1. A Deep Learning Framework Identifies Pathogenic Noncoding Somatic Mutations from Personal Prostate Cancer Genomes.
Wang C; Li J
Cancer Res; 2020 Nov; 80(21):4644-4654. PubMed ID: 32907840
[TBL] [Abstract][Full Text] [Related]
2. Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer.
Jaratlerdsiri W; Chan EKF; Gong T; Petersen DC; Kalsbeek AMF; Venter PA; Stricker PD; Bornman MSR; Hayes VM
Cancer Res; 2018 Dec; 78(24):6736-6746. PubMed ID: 30217929
[TBL] [Abstract][Full Text] [Related]
3. Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles, Somatic Mutations, and 3D Genomic Architecture.
Yuan J; Houlahan KE; Ramanand SG; Lee S; Baek G; Yang Y; Chen Y; Strand DW; Zhang MQ; Boutros PC; Mani RS
Cancer Discov; 2022 Dec; 12(12):2838-2855. PubMed ID: 36108240
[TBL] [Abstract][Full Text] [Related]
4. Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors.
Hawley JR; Zhou S; Arlidge C; Grillo G; Kron KJ; Hugh-White R; van der Kwast TH; Fraser M; Boutros PC; Bristow RG; Lupien M
Cancer Res; 2021 Dec; 81(23):5833-5848. PubMed ID: 34642184
[TBL] [Abstract][Full Text] [Related]
5. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
[TBL] [Abstract][Full Text] [Related]
6. Leveraging Tissue-Specific Enhancer-Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung Cancer.
Hariprakash JM; Salviato E; La Mastra F; Sebestyén E; Tagliaferri I; Silva RS; Lucini F; Farina L; Cinquanta M; Rancati I; Riboni M; Minardi SP; Roz L; Gorini F; Lanzuolo C; Casola S; Ferrari F
Cancer Res; 2024 Jan; 84(1):133-153. PubMed ID: 37855660
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of cancer tissue reveals that somatic mutations commonly occur in a specific motif.
Makridakis NM; Caldas Ferraz LF; Reichardt JK
Hum Mutat; 2009 Jan; 30(1):39-48. PubMed ID: 18623241
[TBL] [Abstract][Full Text] [Related]
8. Chromatin structure-based prediction of recurrent noncoding mutations in cancer.
Kim K; Jang K; Yang W; Choi EY; Park SM; Bae M; Kim YJ; Choi JK
Nat Genet; 2016 Nov; 48(11):1321-1326. PubMed ID: 27723759
[TBL] [Abstract][Full Text] [Related]
9. Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
Lowdon RF; Wang T
PLoS One; 2017; 12(3):e0174032. PubMed ID: 28333948
[TBL] [Abstract][Full Text] [Related]
10. Whole-genome deep-learning analysis identifies contribution of noncoding mutations to autism risk.
Zhou J; Park CY; Theesfeld CL; Wong AK; Yuan Y; Scheckel C; Fak JJ; Funk J; Yao K; Tajima Y; Packer A; Darnell RB; Troyanskaya OG
Nat Genet; 2019 Jun; 51(6):973-980. PubMed ID: 31133750
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of somatic noncoding mutation patterns in cancer.
Dietlein F; Wang AB; Fagre C; Tang A; Besselink NJM; Cuppen E; Li C; Sunyaev SR; Neal JT; Van Allen EM
Science; 2022 Apr; 376(6589):eabg5601. PubMed ID: 35389777
[TBL] [Abstract][Full Text] [Related]
12. The prostate cancer genome: perspectives and potential.
Barbieri CE; Tomlins SA
Urol Oncol; 2014 Jan; 32(1):53.e15-22. PubMed ID: 24239470
[TBL] [Abstract][Full Text] [Related]
13. Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer.
Kalsbeek AM; Chan EF; Grogan J; Petersen DC; Jaratlerdsiri W; Gupta R; Lyons RJ; Haynes AM; Horvath LG; Kench JG; Stricker PD; Hayes VM
Aging (Albany NY); 2016 Oct; 8(11):2702-2712. PubMed ID: 27705925
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
Fujimoto A; Furuta M; Totoki Y; Tsunoda T; Kato M; Shiraishi Y; Tanaka H; Taniguchi H; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Wardell CP; Hayami S; Nakamura T; Aikata H; Arihiro K; Boroevich KA; Abe T; Nakano K; Maejima K; Sasaki-Oku A; Ohsawa A; Shibuya T; Nakamura H; Hama N; Hosoda F; Arai Y; Ohashi S; Urushidate T; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Ojima H; Hiraoka N; Okusaka T; Kubo M; Marubashi S; Yamada T; Hirano S; Yamamoto M; Ohdan H; Shimada K; Ishikawa O; Yamaue H; Chayama K; Miyano S; Aburatani H; Shibata T; Nakagawa H
Nat Genet; 2016 May; 48(5):500-9. PubMed ID: 27064257
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
[TBL] [Abstract][Full Text] [Related]
17. Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma.
Capasso M; Lasorsa VA; Cimmino F; Avitabile M; Cantalupo S; Montella A; De Angelis B; Morini M; de Torres C; Castellano A; Locatelli F; Iolascon A
Cancer Res; 2020 Feb; 80(3):382-393. PubMed ID: 31784426
[TBL] [Abstract][Full Text] [Related]
18. Reprint of: The prostate cancer genome: Perspectives and potential.
Barbieri CE; Tomlins SA
Urol Oncol; 2015 Feb; 33(2):95-102. PubMed ID: 25726356
[TBL] [Abstract][Full Text] [Related]
19. Novel lncRNA
Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
[TBL] [Abstract][Full Text] [Related]
20. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
